Grupo de Investigación de Endocrinología, Diabetes, Nutrición, alteraciones Renales y Salud Infantil - GIC 21/144
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Clínico San Carlos de Madrid (31)
2024
-
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433
2021
-
Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications (Scientific Reports, (2021), 11, 1, (1526), 10.1038/s41598-021-81093-y)
Scientific Reports
-
Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study
Scientific Reports, Vol. 11, Núm. 1
-
Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications
Scientific Reports, Vol. 11, Núm. 1
2020
-
Incidence and regression of metabolic syndrome in a representative sample of the Spanish population: Results of the cohort di@bet.es study
BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1
2019
-
Dairy product consumption and metabolic diseases in the Di@bet.es study
Nutrients, Vol. 11, Núm. 2
2018
-
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial
JAMA - Journal of the American Medical Association, Vol. 319, Núm. 1, pp. 38-48
-
What to consider when pseudohypoparathyroidism is ruled out: IPPSD and differential diagnosis
BMC Medical Genetics, Vol. 19, Núm. 1
2016
-
Low physical activity and its association with diabetes and other cardiovascular risk factors: A nationwide, population-based study
PLoS ONE, Vol. 11, Núm. 8
-
Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es
Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 572-578
2015
-
Estimating cardiovascular risk in Spain by the European guidelines on cardiovascular disease prevention in clinical practice
Revista Espanola de Cardiologia, Vol. 68, Núm. 5, pp. 417-425
2014
-
Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants
Gut, Vol. 63, Núm. 3, pp. 415-422
-
Modifications of the homeostasis model assessment of insulin resistance index with age
Acta Diabetologica, Vol. 51, Núm. 6, pp. 917-925
-
Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study
Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114
-
Prevalencia de obesidad, diabetes mellitus y otros factores de riesgo cardiovascular en Andalucía. Comparación con datos de prevalencia nacionales. Estudio Di@bet.es
Revista Espanola de Cardiologia, Vol. 67, Núm. 6, pp. 442-448
-
The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study
Diabetes Technology and Therapeutics, Vol. 16, Núm. 7, pp. 435-441
-
Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955
2013
-
Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es
Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863
-
Factors affecting levels of urinary albumin excretion in the general population of Spain: The Di@bet.es study
Clinical Science, Vol. 124, Núm. 4, pp. 269-277
-
Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study
European Journal of Clinical Investigation, Vol. 43, Núm. 1, pp. 1-10